Microport
Microport
Microport mainly engages in medical research and medical equipment production.
MicroPort, established in 1998, is a medical device manufacturer. The company's products cover ten major fields, such as implants, orthopedic medical devices, aortic and puncture vascular intervention products, electrophysiological medical devices and nerve implant products. Founded by Chang Yaohua, it went public on the Hong Kong Stock Exchange. The shareholders are Otsuka, Maxwell Maxcare Science, Shanghai ZJ Hi-Tech Investment, Starwick Investments. Microport's direct competitors include Lepu Medical and Weigao.
- All
- News
- Analysis
- Research
Briefing Jan 31, 2023 11:02 AM
· Healthcare
Fine Vision Completes Angel Financing Round Worth Nearly CNY 50 Mn
Briefing Jan 28, 2023 11:20 AM
· Healthcare
YingHe Neuro Raises Over CNY 100 Mn in Angel Round
In-depth
Briefing Jan 17, 2023 10:36 AM
· Healthcare
Medical Equipment Company PowerSite Nets Over CNY 100 Mn in Series B
Briefing Jan 13, 2023 11:03 AM
· Healthcare
Equipment Company Keyto Nets Over CNY 100 Mn in Series C
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 22, 2021 03:11 PM
Briefing Jan 12, 2023 10:53 AM
· Healthcare
IVD Company Bioantibody Nets Over CNY 100 Mn in Series A
Briefing Jan 12, 2023 10:25 AM
· Healthcare
Surgical Robot Platform Company KouTech Nets Over USD 10 Mn in Series A+ Round
Briefing Sep 09, 2022 04:12 PM
· Healthcare
Trulive Nets Hundreds of Mns of CNY in pre-Series B Financing Round
Briefing Sep 05, 2022 04:50 PM
· Healthcare
LinkZill Nets Tens of Millions of CNY in pre-Series A+
Healthcare
Dynamic Biosystems Snags Nearly CNY 100 Mn in Series A+
Dynamic Biosystems is a single cell and space multi-omics technology platform enterprise. The company focuses on exploring the huge potential in the fields of precision medicine of tumor, eugenics and fertility, and drug discovery, and is committed to promoting precision medicine to the era of single cell and space omics, helping life science and clinical medicine.
Feb 06, 2023 07:25 PM
In-depth
Healthcare
Tsingke Biotechnology: More Opportunities in the International Market of Gene Synthesis
‘Globalization is the only way to the development of the industry. It is more conducive to the rapid progress of the industry for domestic enterprises to compete with well-known overseas enterprises.’
Jan 30, 2023 02:13 PM
Briefing Aug 01, 2022 03:11 PM
· Healthcare
Biomedical Lab Supplies Producer Acumen Bags 100 Mn of CNY in Series A Round
Briefing Dec 28, 2021 11:59 PM
· Healthcare
Minimally invasive medicine proposes to spin off minimally invasive brain science and list it independently on the main board of the stock exchange
Insight
Briefing Oct 30, 2021 10:44 AM
· Healthcare
Minimally invasive group investment holding Argus strengthens the multi-dimensional layout of precision medicine in the pan vascular field
Briefing Dec 11, 2020 09:57 PM
· Healthcare
Minimally invasive medical treatment: considering the separation of minimally invasive medical robot and independent listing
Briefing Updated 1 hour ago
· Healthcare
Medical Technology Company MacroLux Nets Nearly CNY 100 Mn in Series A
See more
Related Companies
